The global Influenza Drugs and Vaccines market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period.
The USA market for Global Influenza Drugs and Vaccines market is estimated to increase from USD million in 2023 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
The China market for Global Influenza Drugs and Vaccines market is estimated to increase from USD million in 2023 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
The Europe market for Global Peak Flowmeter market is estimated to increase from USD million in 2023 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
This research report provides a comprehensive analysis of the Influenza Drugs and Vaccines market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Influenza Drugs and Vaccines market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Influenza Drugs and Vaccines, challenges faced by the industry, and potential opportunities for market players.
The global Influenza Drugs and Vaccines market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Influenza Drugs and Vaccines market presents opportunities for various stakeholders, including Hospital Pharmacy, Retail Pharmacy. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Influenza Drugs and Vaccines market. Additionally, the growing consumer demand present avenues for market expansion.
The global pharmaceutical market is 1475 billion US$ in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion US$ in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The research report on the Influenza Drugs and Vaccines market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Influenza Drugs and Vaccines market.
Market Overview: The report provides a comprehensive overview of the Influenza Drugs and Vaccines market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Influenza Drugs, Influenza Vaccines), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Influenza Drugs and Vaccines market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Influenza Drugs and Vaccines market's trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Influenza Drugs and Vaccines market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Influenza Drugs and Vaccines market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Influenza Drugs and Vaccines market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Influenza Drugs and Vaccines market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Influenza Drugs and Vaccines, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Influenza Drugs and Vaccines market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Influenza Drugs and Vaccines market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
- Influenza Drugs
- Influenza Vaccines
Market segment by Application
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
Global Influenza Drugs and Vaccines Market Segment Percentages, By Region and Country, 2023 (%)
- North America (United States, Canada, Mexico)
- Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe)
- Asia-Pacific (China, India, Japan, South Korea, Australia, Rest of APAC)
- The Middle East and Africa (Middle East, Africa)
- South and Central America (Brazil, Argentina, Rest of SCA)
Major players covered
- CSL
- Bristol Myers Squibb
- AstraZeneca
- Eli Lilly
- Roche
- GlaxoSmithKline
- Novartis
- Pfizer
- Sanofi
- Bayer
- Celgene
- Seqirus
- Protein Sciences Corporation
- Serum Institute of India
- Emergent Biosolutions
- BioCryst Pharmaceuticals
- Alvogen
- Viatris
- Hulan Bio
- Changchun Institute of Biological
- Jiangsu GDK
- Sinovac
- Beike Bio
Outline of Major Chapters:
Chapter 1: Introduces the definition of Influenza Drugs and Vaccines, market overview.
Chapter 2: Global Influenza Drugs and Vaccines market size in revenue and volume.
Chapter 3: Detailed analysis of Influenza Drugs and Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Influenza Drugs and Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Influenza Drugs and Vaccines capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Influenza Drugs and Vaccines Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Influenza Drugs and Vaccines Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Influenza Drugs and Vaccines Overall Market Size
2.1 Global Influenza Drugs and Vaccines Market Size: 2023 VS 2030
2.2 Global Influenza Drugs and Vaccines Revenue, Prospects & Forecasts: 2019-2030
2.3 Global Influenza Drugs and Vaccines Sales: 2019-2030
3 Company Landscape
3.1 Top Influenza Drugs and Vaccines Players in Global Market
3.2 Top Global Influenza Drugs and Vaccines Companies Ranked by Revenue
3.3 Global Influenza Drugs and Vaccines Revenue by Companies
3.4 Global Influenza Drugs and Vaccines Sales by Companies
3.5 Global Influenza Drugs and Vaccines Price by Manufacturer (2019-2024)
3.6 Top 3 and Top 5 Influenza Drugs and Vaccines Companies in Global Market, by Revenue in 2023
3.7 Global Manufacturers Influenza Drugs and Vaccines Product Type
3.8 Tier 1, Tier 2 and Tier 3 Influenza Drugs and Vaccines Players in Global Market
3.8.1 List of Global Tier 1 Influenza Drugs and Vaccines Companies
3.8.2 List of Global Tier 2 and Tier 3 Influenza Drugs and Vaccines Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Influenza Drugs and Vaccines Market Size Markets, 2023 & 2030
4.1.2 Influenza Drugs
4.1.3 Influenza Vaccines
4.2 By Type - Global Influenza Drugs and Vaccines Revenue & Forecasts
4.2.1 By Type - Global Influenza Drugs and Vaccines Revenue, 2019-2024
4.2.2 By Type - Global Influenza Drugs and Vaccines Revenue, 2025-2030
4.2.3 By Type - Global Influenza Drugs and Vaccines Revenue Market Share, 2019-2030
4.3 By Type - Global Influenza Drugs and Vaccines Sales & Forecasts
4.3.1 By Type - Global Influenza Drugs and Vaccines Sales, 2019-2024
4.3.2 By Type - Global Influenza Drugs and Vaccines Sales, 2025-2030
4.3.3 By Type - Global Influenza Drugs and Vaccines Sales Market Share, 2019-2030
4.4 By Type - Global Influenza Drugs and Vaccines Price (Manufacturers Selling Prices), 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Influenza Drugs and Vaccines Market Size, 2023 & 2030
5.1.2 Hospital Pharmacy
5.1.3 Retail Pharmacy
5.1.4 Online Pharmacy
5.2 By Application - Global Influenza Drugs and Vaccines Revenue & Forecasts
5.2.1 By Application - Global Influenza Drugs and Vaccines Revenue, 2019-2024
5.2.2 By Application - Global Influenza Drugs and Vaccines Revenue, 2025-2030
5.2.3 By Application - Global Influenza Drugs and Vaccines Revenue Market Share, 2019-2030
5.3 By Application - Global Influenza Drugs and Vaccines Sales & Forecasts
5.3.1 By Application - Global Influenza Drugs and Vaccines Sales, 2019-2024
5.3.2 By Application - Global Influenza Drugs and Vaccines Sales, 2025-2030
5.3.3 By Application - Global Influenza Drugs and Vaccines Sales Market Share, 2019-2030
5.4 By Application - Global Influenza Drugs and Vaccines Price (Manufacturers Selling Prices), 2019-2030
6 Sights by Region
6.1 By Region - Global Influenza Drugs and Vaccines Market Size, 2023 & 2030
6.2 By Region - Global Influenza Drugs and Vaccines Revenue & Forecasts
6.2.1 By Region - Global Influenza Drugs and Vaccines Revenue, 2019-2024
6.2.2 By Region - Global Influenza Drugs and Vaccines Revenue, 2025-2030
6.2.3 By Region - Global Influenza Drugs and Vaccines Revenue Market Share, 2019-2030
6.3 By Region - Global Influenza Drugs and Vaccines Sales & Forecasts
6.3.1 By Region - Global Influenza Drugs and Vaccines Sales, 2019-2024
6.3.2 By Region - Global Influenza Drugs and Vaccines Sales, 2025-2030
6.3.3 By Region - Global Influenza Drugs and Vaccines Sales Market Share, 2019-2030
6.4 North America
6.4.1 By Country - North America Influenza Drugs and Vaccines Revenue, 2019-2030
6.4.2 By Country - North America Influenza Drugs and Vaccines Sales, 2019-2030
6.4.3 US Influenza Drugs and Vaccines Market Size, 2019-2030
6.4.4 Canada Influenza Drugs and Vaccines Market Size, 2019-2030
6.4.5 Mexico Influenza Drugs and Vaccines Market Size, 2019-2030
6.5 Europe
6.5.1 By Country - Europe Influenza Drugs and Vaccines Revenue, 2019-2030
6.5.2 By Country - Europe Influenza Drugs and Vaccines Sales, 2019-2030
6.5.3 Germany Influenza Drugs and Vaccines Market Size, 2019-2030
6.5.4 France Influenza Drugs and Vaccines Market Size, 2019-2030
6.5.5 U.K. Influenza Drugs and Vaccines Market Size, 2019-2030
6.5.6 Italy Influenza Drugs and Vaccines Market Size, 2019-2030
6.5.7 Russia Influenza Drugs and Vaccines Market Size, 2019-2030
6.5.8 Nordic Countries Influenza Drugs and Vaccines Market Size, 2019-2030
6.5.9 Benelux Influenza Drugs and Vaccines Market Size, 2019-2030
6.6 Asia
6.6.1 By Region - Asia Influenza Drugs and Vaccines Revenue, 2019-2030
6.6.2 By Region - Asia Influenza Drugs and Vaccines Sales, 2019-2030
6.6.3 China Influenza Drugs and Vaccines Market Size, 2019-2030
6.6.4 Japan Influenza Drugs and Vaccines Market Size, 2019-2030
6.6.5 South Korea Influenza Drugs and Vaccines Market Size, 2019-2030
6.6.6 Southeast Asia Influenza Drugs and Vaccines Market Size, 2019-2030
6.6.7 India Influenza Drugs and Vaccines Market Size, 2019-2030
6.7 South America
6.7.1 By Country - South America Influenza Drugs and Vaccines Revenue, 2019-2030
6.7.2 By Country - South America Influenza Drugs and Vaccines Sales, 2019-2030
6.7.3 Brazil Influenza Drugs and Vaccines Market Size, 2019-2030
6.7.4 Argentina Influenza Drugs and Vaccines Market Size, 2019-2030
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Influenza Drugs and Vaccines Revenue, 2019-2030
6.8.2 By Country - Middle East & Africa Influenza Drugs and Vaccines Sales, 2019-2030
6.8.3 Turkey Influenza Drugs and Vaccines Market Size, 2019-2030
6.8.4 Israel Influenza Drugs and Vaccines Market Size, 2019-2030
6.8.5 Saudi Arabia Influenza Drugs and Vaccines Market Size, 2019-2030
6.8.6 UAE Influenza Drugs and Vaccines Market Size, 2019-2030
7 Manufacturers & Brands Profiles
7.1 CSL
7.1.1 CSL Company Summary
7.1.2 CSL Business Overview
7.1.3 CSL Influenza Drugs and Vaccines Major Product Offerings
7.1.4 CSL Influenza Drugs and Vaccines Sales and Revenue in Global (2019-2024)
7.1.5 CSL Key News & Latest Developments
7.2 Bristol Myers Squibb
7.2.1 Bristol Myers Squibb Company Summary
7.2.2 Bristol Myers Squibb Business Overview
7.2.3 Bristol Myers Squibb Influenza Drugs and Vaccines Major Product Offerings
7.2.4 Bristol Myers Squibb Influenza Drugs and Vaccines Sales and Revenue in Global (2019-2024)
7.2.5 Bristol Myers Squibb Key News & Latest Developments
7.3 AstraZeneca
7.3.1 AstraZeneca Company Summary
7.3.2 AstraZeneca Business Overview
7.3.3 AstraZeneca Influenza Drugs and Vaccines Major Product Offerings
7.3.4 AstraZeneca Influenza Drugs and Vaccines Sales and Revenue in Global (2019-2024)
7.3.5 AstraZeneca Key News & Latest Developments
7.4 Eli Lilly
7.4.1 Eli Lilly Company Summary
7.4.2 Eli Lilly Business Overview
7.4.3 Eli Lilly Influenza Drugs and Vaccines Major Product Offerings
7.4.4 Eli Lilly Influenza Drugs and Vaccines Sales and Revenue in Global (2019-2024)
7.4.5 Eli Lilly Key News & Latest Developments
7.5 Roche
7.5.1 Roche Company Summary
7.5.2 Roche Business Overview
7.5.3 Roche Influenza Drugs and Vaccines Major Product Offerings
7.5.4 Roche Influenza Drugs and Vaccines Sales and Revenue in Global (2019-2024)
7.5.5 Roche Key News & Latest Developments
7.6 GlaxoSmithKline
7.6.1 GlaxoSmithKline Company Summary
7.6.2 GlaxoSmithKline Business Overview
7.6.3 GlaxoSmithKline Influenza Drugs and Vaccines Major Product Offerings
7.6.4 GlaxoSmithKline Influenza Drugs and Vaccines Sales and Revenue in Global (2019-2024)
7.6.5 GlaxoSmithKline Key News & Latest Developments
7.7 Novartis
7.7.1 Novartis Company Summary
7.7.2 Novartis Business Overview
7.7.3 Novartis Influenza Drugs and Vaccines Major Product Offerings
7.7.4 Novartis Influenza Drugs and Vaccines Sales and Revenue in Global (2019-2024)
7.7.5 Novartis Key News & Latest Developments
7.8 Pfizer
7.8.1 Pfizer Company Summary
7.8.2 Pfizer Business Overview
7.8.3 Pfizer Influenza Drugs and Vaccines Major Product Offerings
7.8.4 Pfizer Influenza Drugs and Vaccines Sales and Revenue in Global (2019-2024)
7.8.5 Pfizer Key News & Latest Developments
7.9 Sanofi
7.9.1 Sanofi Company Summary
7.9.2 Sanofi Business Overview
7.9.3 Sanofi Influenza Drugs and Vaccines Major Product Offerings
7.9.4 Sanofi Influenza Drugs and Vaccines Sales and Revenue in Global (2019-2024)
7.9.5 Sanofi Key News & Latest Developments
7.10 Bayer
7.10.1 Bayer Company Summary
7.10.2 Bayer Business Overview
7.10.3 Bayer Influenza Drugs and Vaccines Major Product Offerings
7.10.4 Bayer Influenza Drugs and Vaccines Sales and Revenue in Global (2019-2024)
7.10.5 Bayer Key News & Latest Developments
7.11 Celgene
7.11.1 Celgene Company Summary
7.11.2 Celgene Business Overview
7.11.3 Celgene Influenza Drugs and Vaccines Major Product Offerings
7.11.4 Celgene Influenza Drugs and Vaccines Sales and Revenue in Global (2019-2024)
7.11.5 Celgene Key News & Latest Developments
7.12 Seqirus
7.12.1 Seqirus Company Summary
7.12.2 Seqirus Business Overview
7.12.3 Seqirus Influenza Drugs and Vaccines Major Product Offerings
7.12.4 Seqirus Influenza Drugs and Vaccines Sales and Revenue in Global (2019-2024)
7.12.5 Seqirus Key News & Latest Developments
7.13 Protein Sciences Corporation
7.13.1 Protein Sciences Corporation Company Summary
7.13.2 Protein Sciences Corporation Business Overview
7.13.3 Protein Sciences Corporation Influenza Drugs and Vaccines Major Product Offerings
7.13.4 Protein Sciences Corporation Influenza Drugs and Vaccines Sales and Revenue in Global (2019-2024)
7.13.5 Protein Sciences Corporation Key News & Latest Developments
7.14 Serum Institute of India
7.14.1 Serum Institute of India Company Summary
7.14.2 Serum Institute of India Business Overview
7.14.3 Serum Institute of India Influenza Drugs and Vaccines Major Product Offerings
7.14.4 Serum Institute of India Influenza Drugs and Vaccines Sales and Revenue in Global (2019-2024)
7.14.5 Serum Institute of India Key News & Latest Developments
7.15 Emergent Biosolutions
7.15.1 Emergent Biosolutions Company Summary
7.15.2 Emergent Biosolutions Business Overview
7.15.3 Emergent Biosolutions Influenza Drugs and Vaccines Major Product Offerings
7.15.4 Emergent Biosolutions Influenza Drugs and Vaccines Sales and Revenue in Global (2019-2024)
7.15.5 Emergent Biosolutions Key News & Latest Developments
7.16 BioCryst Pharmaceuticals
7.16.1 BioCryst Pharmaceuticals Company Summary
7.16.2 BioCryst Pharmaceuticals Business Overview
7.16.3 BioCryst Pharmaceuticals Influenza Drugs and Vaccines Major Product Offerings
7.16.4 BioCryst Pharmaceuticals Influenza Drugs and Vaccines Sales and Revenue in Global (2019-2024)
7.16.5 BioCryst Pharmaceuticals Key News & Latest Developments
7.17 Alvogen
7.17.1 Alvogen Company Summary
7.17.2 Alvogen Business Overview
7.17.3 Alvogen Influenza Drugs and Vaccines Major Product Offerings
7.17.4 Alvogen Influenza Drugs and Vaccines Sales and Revenue in Global (2019-2024)
7.17.5 Alvogen Key News & Latest Developments
7.18 Viatris
7.18.1 Viatris Company Summary
7.18.2 Viatris Business Overview
7.18.3 Viatris Influenza Drugs and Vaccines Major Product Offerings
7.18.4 Viatris Influenza Drugs and Vaccines Sales and Revenue in Global (2019-2024)
7.18.5 Viatris Key News & Latest Developments
7.19 Hulan Bio
7.19.1 Hulan Bio Company Summary
7.19.2 Hulan Bio Business Overview
7.19.3 Hulan Bio Influenza Drugs and Vaccines Major Product Offerings
7.19.4 Hulan Bio Influenza Drugs and Vaccines Sales and Revenue in Global (2019-2024)
7.19.5 Hulan Bio Key News & Latest Developments
7.20 Changchun Institute of Biological
7.20.1 Changchun Institute of Biological Company Summary
7.20.2 Changchun Institute of Biological Business Overview
7.20.3 Changchun Institute of Biological Influenza Drugs and Vaccines Major Product Offerings
7.20.4 Changchun Institute of Biological Influenza Drugs and Vaccines Sales and Revenue in Global (2019-2024)
7.20.5 Changchun Institute of Biological Key News & Latest Developments
7.21 Jiangsu GDK
7.21.1 Jiangsu GDK Company Summary
7.21.2 Jiangsu GDK Business Overview
7.21.3 Jiangsu GDK Influenza Drugs and Vaccines Major Product Offerings
7.21.4 Jiangsu GDK Influenza Drugs and Vaccines Sales and Revenue in Global (2019-2024)
7.21.5 Jiangsu GDK Key News & Latest Developments
7.22 Sinovac
7.22.1 Sinovac Company Summary
7.22.2 Sinovac Business Overview
7.22.3 Sinovac Influenza Drugs and Vaccines Major Product Offerings
7.22.4 Sinovac Influenza Drugs and Vaccines Sales and Revenue in Global (2019-2024)
7.22.5 Sinovac Key News & Latest Developments
7.23 Beike Bio
7.23.1 Beike Bio Company Summary
7.23.2 Beike Bio Business Overview
7.23.3 Beike Bio Influenza Drugs and Vaccines Major Product Offerings
7.23.4 Beike Bio Influenza Drugs and Vaccines Sales and Revenue in Global (2019-2024)
7.23.5 Beike Bio Key News & Latest Developments
8 Global Influenza Drugs and Vaccines Production Capacity, Analysis
8.1 Global Influenza Drugs and Vaccines Production Capacity, 2019-2030
8.2 Influenza Drugs and Vaccines Production Capacity of Key Manufacturers in Global Market
8.3 Global Influenza Drugs and Vaccines Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Influenza Drugs and Vaccines Supply Chain Analysis
10.1 Influenza Drugs and Vaccines Industry Value Chain
10.2 Influenza Drugs and Vaccines Upstream Market
10.3 Influenza Drugs and Vaccines Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Influenza Drugs and Vaccines Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Influenza Drugs and Vaccines in Global Market
Table 2. Top Influenza Drugs and Vaccines Players in Global Market, Ranking by Revenue (2023)
Table 3. Global Influenza Drugs and Vaccines Revenue by Companies, (US$, Mn), 2019-2024
Table 4. Global Influenza Drugs and Vaccines Revenue Share by Companies, 2019-2024
Table 5. Global Influenza Drugs and Vaccines Sales by Companies, (Tons), 2019-2024
Table 6. Global Influenza Drugs and Vaccines Sales Share by Companies, 2019-2024
Table 7. Key Manufacturers Influenza Drugs and Vaccines Price (2019-2024) & (US$/Kg)
Table 8. Global Manufacturers Influenza Drugs and Vaccines Product Type
Table 9. List of Global Tier 1 Influenza Drugs and Vaccines Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Influenza Drugs and Vaccines Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global Influenza Drugs and Vaccines Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Global Influenza Drugs and Vaccines Revenue (US$, Mn), 2019-2024
Table 13. By Type - Global Influenza Drugs and Vaccines Revenue (US$, Mn), 2025-2030
Table 14. By Type - Global Influenza Drugs and Vaccines Sales (Tons), 2019-2024
Table 15. By Type - Global Influenza Drugs and Vaccines Sales (Tons), 2025-2030
Table 16. By Application ? Global Influenza Drugs and Vaccines Revenue, (US$, Mn), 2023 & 2030
Table 17. By Application - Global Influenza Drugs and Vaccines Revenue (US$, Mn), 2019-2024
Table 18. By Application - Global Influenza Drugs and Vaccines Revenue (US$, Mn), 2025-2030
Table 19. By Application - Global Influenza Drugs and Vaccines Sales (Tons), 2019-2024
Table 20. By Application - Global Influenza Drugs and Vaccines Sales (Tons), 2025-2030
Table 21. By Region ? Global Influenza Drugs and Vaccines Revenue, (US$, Mn), 2023 VS 2030
Table 22. By Region - Global Influenza Drugs and Vaccines Revenue (US$, Mn), 2019-2024
Table 23. By Region - Global Influenza Drugs and Vaccines Revenue (US$, Mn), 2025-2030
Table 24. By Region - Global Influenza Drugs and Vaccines Sales (Tons), 2019-2024
Table 25. By Region - Global Influenza Drugs and Vaccines Sales (Tons), 2025-2030
Table 26. By Country - North America Influenza Drugs and Vaccines Revenue, (US$, Mn), 2019-2024
Table 27. By Country - North America Influenza Drugs and Vaccines Revenue, (US$, Mn), 2025-2030
Table 28. By Country - North America Influenza Drugs and Vaccines Sales, (Tons), 2019-2024
Table 29. By Country - North America Influenza Drugs and Vaccines Sales, (Tons), 2025-2030
Table 30. By Country - Europe Influenza Drugs and Vaccines Revenue, (US$, Mn), 2019-2024
Table 31. By Country - Europe Influenza Drugs and Vaccines Revenue, (US$, Mn), 2025-2030
Table 32. By Country - Europe Influenza Drugs and Vaccines Sales, (Tons), 2019-2024
Table 33. By Country - Europe Influenza Drugs and Vaccines Sales, (Tons), 2025-2030
Table 34. By Region - Asia Influenza Drugs and Vaccines Revenue, (US$, Mn), 2019-2024
Table 35. By Region - Asia Influenza Drugs and Vaccines Revenue, (US$, Mn), 2025-2030
Table 36. By Region - Asia Influenza Drugs and Vaccines Sales, (Tons), 2019-2024
Table 37. By Region - Asia Influenza Drugs and Vaccines Sales, (Tons), 2025-2030
Table 38. By Country - South America Influenza Drugs and Vaccines Revenue, (US$, Mn), 2019-2024
Table 39. By Country - South America Influenza Drugs and Vaccines Revenue, (US$, Mn), 2025-2030
Table 40. By Country - South America Influenza Drugs and Vaccines Sales, (Tons), 2019-2024
Table 41. By Country - South America Influenza Drugs and Vaccines Sales, (Tons), 2025-2030
Table 42. By Country - Middle East & Africa Influenza Drugs and Vaccines Revenue, (US$, Mn), 2019-2024
Table 43. By Country - Middle East & Africa Influenza Drugs and Vaccines Revenue, (US$, Mn), 2025-2030
Table 44. By Country - Middle East & Africa Influenza Drugs and Vaccines Sales, (Tons), 2019-2024
Table 45. By Country - Middle East & Africa Influenza Drugs and Vaccines Sales, (Tons), 2025-2030
Table 46. CSL Company Summary
Table 47. CSL Influenza Drugs and Vaccines Product Offerings
Table 48. CSL Influenza Drugs and Vaccines Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Kg) (2019-2024)
Table 49. CSL Key News & Latest Developments
Table 50. Bristol Myers Squibb Company Summary
Table 51. Bristol Myers Squibb Influenza Drugs and Vaccines Product Offerings
Table 52. Bristol Myers Squibb Influenza Drugs and Vaccines Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Kg) (2019-2024)
Table 53. Bristol Myers Squibb Key News & Latest Developments
Table 54. AstraZeneca Company Summary
Table 55. AstraZeneca Influenza Drugs and Vaccines Product Offerings
Table 56. AstraZeneca Influenza Drugs and Vaccines Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Kg) (2019-2024)
Table 57. AstraZeneca Key News & Latest Developments
Table 58. Eli Lilly Company Summary
Table 59. Eli Lilly Influenza Drugs and Vaccines Product Offerings
Table 60. Eli Lilly Influenza Drugs and Vaccines Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Kg) (2019-2024)
Table 61. Eli Lilly Key News & Latest Developments
Table 62. Roche Company Summary
Table 63. Roche Influenza Drugs and Vaccines Product Offerings
Table 64. Roche Influenza Drugs and Vaccines Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Kg) (2019-2024)
Table 65. Roche Key News & Latest Developments
Table 66. GlaxoSmithKline Company Summary
Table 67. GlaxoSmithKline Influenza Drugs and Vaccines Product Offerings
Table 68. GlaxoSmithKline Influenza Drugs and Vaccines Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Kg) (2019-2024)
Table 69. GlaxoSmithKline Key News & Latest Developments
Table 70. Novartis Company Summary
Table 71. Novartis Influenza Drugs and Vaccines Product Offerings
Table 72. Novartis Influenza Drugs and Vaccines Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Kg) (2019-2024)
Table 73. Novartis Key News & Latest Developments
Table 74. Pfizer Company Summary
Table 75. Pfizer Influenza Drugs and Vaccines Product Offerings
Table 76. Pfizer Influenza Drugs and Vaccines Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Kg) (2019-2024)
Table 77. Pfizer Key News & Latest Developments
Table 78. Sanofi Company Summary
Table 79. Sanofi Influenza Drugs and Vaccines Product Offerings
Table 80. Sanofi Influenza Drugs and Vaccines Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Kg) (2019-2024)
Table 81. Sanofi Key News & Latest Developments
Table 82. Bayer Company Summary
Table 83. Bayer Influenza Drugs and Vaccines Product Offerings
Table 84. Bayer Influenza Drugs and Vaccines Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Kg) (2019-2024)
Table 85. Bayer Key News & Latest Developments
Table 86. Celgene Company Summary
Table 87. Celgene Influenza Drugs and Vaccines Product Offerings
Table 88. Celgene Influenza Drugs and Vaccines Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Kg) (2019-2024)
Table 89. Celgene Key News & Latest Developments
Table 90. Seqirus Company Summary
Table 91. Seqirus Influenza Drugs and Vaccines Product Offerings
Table 92. Seqirus Influenza Drugs and Vaccines Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Kg) (2019-2024)
Table 93. Seqirus Key News & Latest Developments
Table 94. Protein Sciences Corporation Company Summary
Table 95. Protein Sciences Corporation Influenza Drugs and Vaccines Product Offerings
Table 96. Protein Sciences Corporation Influenza Drugs and Vaccines Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Kg) (2019-2024)
Table 97. Protein Sciences Corporation Key News & Latest Developments
Table 98. Serum Institute of India Company Summary
Table 99. Serum Institute of India Influenza Drugs and Vaccines Product Offerings
Table 100. Serum Institute of India Influenza Drugs and Vaccines Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Kg) (2019-2024)
Table 101. Serum Institute of India Key News & Latest Developments
Table 102. Emergent Biosolutions Company Summary
Table 103. Emergent Biosolutions Influenza Drugs and Vaccines Product Offerings
Table 104. Emergent Biosolutions Influenza Drugs and Vaccines Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Kg) (2019-2024)
Table 105. Emergent Biosolutions Key News & Latest Developments
Table 106. BioCryst Pharmaceuticals Company Summary
Table 107. BioCryst Pharmaceuticals Influenza Drugs and Vaccines Product Offerings
Table 108. BioCryst Pharmaceuticals Influenza Drugs and Vaccines Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Kg) (2019-2024)
Table 109. BioCryst Pharmaceuticals Key News & Latest Developments
Table 110. Alvogen Company Summary
Table 111. Alvogen Influenza Drugs and Vaccines Product Offerings
Table 112. Alvogen Influenza Drugs and Vaccines Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Kg) (2019-2024)
Table 113. Alvogen Key News & Latest Developments
Table 114. Viatris Company Summary
Table 115. Viatris Influenza Drugs and Vaccines Product Offerings
Table 116. Viatris Influenza Drugs and Vaccines Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Kg) (2019-2024)
Table 117. Viatris Key News & Latest Developments
Table 118. Hulan Bio Company Summary
Table 119. Hulan Bio Influenza Drugs and Vaccines Product Offerings
Table 120. Hulan Bio Influenza Drugs and Vaccines Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Kg) (2019-2024)
Table 121. Hulan Bio Key News & Latest Developments
Table 122. Changchun Institute of Biological Company Summary
Table 123. Changchun Institute of Biological Influenza Drugs and Vaccines Product Offerings
Table 124. Changchun Institute of Biological Influenza Drugs and Vaccines Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Kg) (2019-2024)
Table 125. Changchun Institute of Biological Key News & Latest Developments
Table 126. Jiangsu GDK Company Summary
Table 127. Jiangsu GDK Influenza Drugs and Vaccines Product Offerings
Table 128. Jiangsu GDK Influenza Drugs and Vaccines Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Kg) (2019-2024)
Table 129. Jiangsu GDK Key News & Latest Developments
Table 130. Sinovac Company Summary
Table 131. Sinovac Influenza Drugs and Vaccines Product Offerings
Table 132. Sinovac Influenza Drugs and Vaccines Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Kg) (2019-2024)
Table 133. Sinovac Key News & Latest Developments
Table 134. Beike Bio Company Summary
Table 135. Beike Bio Influenza Drugs and Vaccines Product Offerings
Table 136. Beike Bio Influenza Drugs and Vaccines Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Kg) (2019-2024)
Table 137. Beike Bio Key News & Latest Developments
Table 138. Influenza Drugs and Vaccines Production Capacity (Tons) of Key Manufacturers in Global Market, 2022-2024 (Tons)
Table 139. Global Influenza Drugs and Vaccines Capacity Market Share of Key Manufacturers, 2022-2024
Table 140. Global Influenza Drugs and Vaccines Production by Region, 2019-2024 (Tons)
Table 141. Global Influenza Drugs and Vaccines Production by Region, 2025-2030 (Tons)
Table 142. Influenza Drugs and Vaccines Market Opportunities & Trends in Global Market
Table 143. Influenza Drugs and Vaccines Market Drivers in Global Market
Table 144. Influenza Drugs and Vaccines Market Restraints in Global Market
Table 145. Influenza Drugs and Vaccines Raw Materials
Table 146. Influenza Drugs and Vaccines Raw Materials Suppliers in Global Market
Table 147. Typical Influenza Drugs and Vaccines Downstream
Table 148. Influenza Drugs and Vaccines Downstream Clients in Global Market
Table 149. Influenza Drugs and Vaccines Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Influenza Drugs and Vaccines Segment by Type in 2023
Figure 2. Influenza Drugs and Vaccines Segment by Application in 2023
Figure 3. Global Influenza Drugs and Vaccines Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Influenza Drugs and Vaccines Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Influenza Drugs and Vaccines Revenue, 2019-2030 (US$, Mn)
Figure 7. Influenza Drugs and Vaccines Sales in Global Market: 2019-2030 (Tons)
Figure 8. The Top 3 and 5 Players Market Share by Influenza Drugs and Vaccines Revenue in 2023
Figure 9. By Type - Global Influenza Drugs and Vaccines Revenue, (US$, Mn), 2023 & 2030
Figure 10. By Type - Global Influenza Drugs and Vaccines Revenue Market Share, 2019-2030
Figure 11. By Type - Global Influenza Drugs and Vaccines Sales Market Share, 2019-2030
Figure 12. By Type - Global Influenza Drugs and Vaccines Price (US$/Kg), 2019-2030
Figure 13. By Application - Global Influenza Drugs and Vaccines Revenue, (US$, Mn), 2023 & 2030
Figure 14. By Application - Global Influenza Drugs and Vaccines Revenue Market Share, 2019-2030
Figure 15. By Application - Global Influenza Drugs and Vaccines Sales Market Share, 2019-2030
Figure 16. By Application - Global Influenza Drugs and Vaccines Price (US$/Kg), 2019-2030
Figure 17. By Region - Global Influenza Drugs and Vaccines Revenue, (US$, Mn), 2023 & 2030
Figure 18. By Region - Global Influenza Drugs and Vaccines Revenue Market Share, 2019 VS 2023 VS 2030
Figure 19. By Region - Global Influenza Drugs and Vaccines Revenue Market Share, 2019-2030
Figure 20. By Region - Global Influenza Drugs and Vaccines Sales Market Share, 2019-2030
Figure 21. By Country - North America Influenza Drugs and Vaccines Revenue Market Share, 2019-2030
Figure 22. By Country - North America Influenza Drugs and Vaccines Sales Market Share, 2019-2030
Figure 23. US Influenza Drugs and Vaccines Revenue, (US$, Mn), 2019-2030
Figure 24. Canada Influenza Drugs and Vaccines Revenue, (US$, Mn), 2019-2030
Figure 25. Mexico Influenza Drugs and Vaccines Revenue, (US$, Mn), 2019-2030
Figure 26. By Country - Europe Influenza Drugs and Vaccines Revenue Market Share, 2019-2030
Figure 27. By Country - Europe Influenza Drugs and Vaccines Sales Market Share, 2019-2030
Figure 28. Germany Influenza Drugs and Vaccines Revenue, (US$, Mn), 2019-2030
Figure 29. France Influenza Drugs and Vaccines Revenue, (US$, Mn), 2019-2030
Figure 30. U.K. Influenza Drugs and Vaccines Revenue, (US$, Mn), 2019-2030
Figure 31. Italy Influenza Drugs and Vaccines Revenue, (US$, Mn), 2019-2030
Figure 32. Russia Influenza Drugs and Vaccines Revenue, (US$, Mn), 2019-2030
Figure 33. Nordic Countries Influenza Drugs and Vaccines Revenue, (US$, Mn), 2019-2030
Figure 34. Benelux Influenza Drugs and Vaccines Revenue, (US$, Mn), 2019-2030
Figure 35. By Region - Asia Influenza Drugs and Vaccines Revenue Market Share, 2019-2030
Figure 36. By Region - Asia Influenza Drugs and Vaccines Sales Market Share, 2019-2030
Figure 37. China Influenza Drugs and Vaccines Revenue, (US$, Mn), 2019-2030
Figure 38. Japan Influenza Drugs and Vaccines Revenue, (US$, Mn), 2019-2030
Figure 39. South Korea Influenza Drugs and Vaccines Revenue, (US$, Mn), 2019-2030
Figure 40. Southeast Asia Influenza Drugs and Vaccines Revenue, (US$, Mn), 2019-2030
Figure 41. India Influenza Drugs and Vaccines Revenue, (US$, Mn), 2019-2030
Figure 42. By Country - South America Influenza Drugs and Vaccines Revenue Market Share, 2019-2030
Figure 43. By Country - South America Influenza Drugs and Vaccines Sales Market Share, 2019-2030
Figure 44. Brazil Influenza Drugs and Vaccines Revenue, (US$, Mn), 2019-2030
Figure 45. Argentina Influenza Drugs and Vaccines Revenue, (US$, Mn), 2019-2030
Figure 46. By Country - Middle East & Africa Influenza Drugs and Vaccines Revenue Market Share, 2019-2030
Figure 47. By Country - Middle East & Africa Influenza Drugs and Vaccines Sales Market Share, 2019-2030
Figure 48. Turkey Influenza Drugs and Vaccines Revenue, (US$, Mn), 2019-2030
Figure 49. Israel Influenza Drugs and Vaccines Revenue, (US$, Mn), 2019-2030
Figure 50. Saudi Arabia Influenza Drugs and Vaccines Revenue, (US$, Mn), 2019-2030
Figure 51. UAE Influenza Drugs and Vaccines Revenue, (US$, Mn), 2019-2030
Figure 52. Global Influenza Drugs and Vaccines Production Capacity (Tons), 2019-2030
Figure 53. The Percentage of Production Influenza Drugs and Vaccines by Region, 2023 VS 2030
Figure 54. Influenza Drugs and Vaccines Industry Value Chain
Figure 55. Marketing Channels
